تعداد نشریات | 20 |
تعداد شمارهها | 1,149 |
تعداد مقالات | 10,518 |
تعداد مشاهده مقاله | 45,420,213 |
تعداد دریافت فایل اصل مقاله | 11,296,234 |
KIR2DS3 is Associated with Protection against Acute Myeloid Leukemia | ||
Iranian Journal of Immunology | ||
مقاله 2، دوره 7، شماره 1، خرداد 2010، صفحه 8-17 اصل مقاله (197.52 K) | ||
نوع مقاله: Original Article | ||
نویسندگان | ||
Farhad Shahsavar1، 2؛ Nader Tajik* 1؛ Kobra-Zinat Entezami1؛ Masoomeh Fallah Radjabzadeh1؛ Behnam Asadifar1؛ Kamran Alimoghaddam3؛ Mohammadreza Ostadali Dahaghi3؛ Arash Jalali3، 4؛ Andisheh Ghashghaie3؛ Ardeshir Ghavamzadeh3 | ||
1Division of Transplant Immunology and Immunogenetics, Department of Immunology, Iran University of Medical Sciences, Tehran, Iran | ||
2Department of Immunology, Lorestan University of Medical Sciences, Khorram Abad, Iran | ||
3Hematology-Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran | ||
4Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran | ||
چکیده | ||
Background: Interaction between killer cell immunoglobulin-like receptors (KIR) and human leukocyte antigen (HLA) class I molecules is important for regulation of natural killer (NK) cell function. Objective: The aim of this study was to investigate the impact of compound KIR-HLA genotype on susceptibility to acute leukemia. Methods: Cohorts of Iranian patients with acute myeloid leukemia (AML; n=40) and acute lymphoid leukemia (ALL; n=38) were genotyped for seventeen KIR genes and their three major HLA class I ligand groups (C1, C2, Bw4) by a combined polymerase chain reaction–sequence-specific primers (PCR-SSP) assay. The results were compared with those of 200 healthy control individuals. Results: We found a significantly decreased frequency of KIR2DS3 in AML patients compared to control group (12.5% vs. 38%, odds ratio=0.23, p=0.0018). Also, the KIR3DS1 was less common in AML group than controls (27.5% vs. 44.5%, p=0.0465, not significant after correction). Other analyses including KIR genotypes, distribution and balance of inhibitory and activating KIR+HLA combinations, and co-inheritance of activating KIR genes with inhibitory KIR+HLA pairs were not significantly different between leukemia patients and the control group. However, in AML patients a trend toward less activating and more inhibitory KIR-HLA state was observed. Interestingly, this situation was not found in ALL patients and inhibition enhancement through increase of HLA ligands and inhibi-tory combinations was the main feature in this group. Conclusion: Our findings may suggest a mechanism for escape of leukemic cells from NK cell immunity. | ||
کلیدواژهها | ||
Acute Leukemia؛ Genotype؛ HLA؛ KIR | ||
آمار تعداد مشاهده مقاله: 1,352 تعداد دریافت فایل اصل مقاله: 849 |